Literature DB >> 14753388

Anthrax vaccine: a review.

John D Grabenstein1.   

Abstract

Anthrax can be a deadly disease if treatment does not begin early in the course of infection. An effective vaccine has been available in the United States since 1970, although it was not used widely until 1998. A comprehensive, peer-reviewed evaluation by the National Academy of Sciences affirmed the findings of multiple previous independent panels that found that the US-licensed anthrax vaccine is safe and effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14753388     DOI: 10.1016/s0889-8561(03)00093-6

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  7 in total

1.  Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.

Authors:  Laura Vitale; Diann Blanset; Israel Lowy; Thomas O'Neill; Joel Goldstein; Stephen F Little; Gerard P Andrews; Gary Dorough; Ronald K Taylor; Tibor Keler
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Authors:  Conrad P Quinn; Carol L Sabourin; Jarad M Schiffer; Nancy A Niemuth; Vera A Semenova; Han Li; Thomas L Rudge; April M Brys; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; Scott D Parker; Janiine Babcock; Wendy Keitel; Gregory A Poland; Harry L Keyserling; Hana El Sahly; Robert M Jacobson; Nina Marano; Brian D Plikaytis; Jennifer G Wright
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  The anthrax vaccine adsorbed vaccine generates protective antigen (PA)-Specific CD4+ T cells with a phenotype distinct from that of naive PA T cells.

Authors:  William W Kwok; Junbao Yang; Eddie James; John Bui; Laurie Huston; Andrew R Wiesen; Michelle Roti
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

Review 4.  Anthrax vaccine and public health policy.

Authors:  Martin Meyer Weiss; Peter D Weiss; Joseph B Weiss
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

5.  Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax.

Authors:  S S Isukapalli; P J Lioy; P G Georgopoulos
Journal:  Risk Anal       Date:  2008-06       Impact factor: 4.000

6.  Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.

Authors:  James C King; Yonghong Gao; Conrad P Quinn; Thomas M Dreier; Cabrini Vianney; Eric M Espeland
Journal:  Vaccine       Date:  2015-04-05       Impact factor: 4.169

Review 7.  Application of radiation technology in vaccines development.

Authors:  Ho Seong Seo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.